本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗,我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示,便表示您已接受我們的網站使用條款。 關閉
FORNEBU, Norway, Feb. 13, 2025 /PRNewswire/ -- Aker Horizons ASA (OSE: AKH), a developer of green energy and industry, today announced results for the fourth quarter 2024. Aker Horizons' net capital employed stood at NOK 5.9 billion, a decrease of NOK 0.2 billion from the third quarter, mainly reflecting AKH's share of results in the portfolio companies in Q4. The company reported a cash position of NOK 2.9 billion and an undrawn credit facility of EUR 500 million, giving available liquidity of NOK 8.8 billion. Main developments in the portfolio: Aker Carbon Capture has proposed a dividend of NOK 3.5 billion, and reports a new contract award in SLB Capturi: - The Board of Directors of ACC ASA has proposed a dividend of NOK 3.5 billion (NOK 1.5 billion to AKH), subject to approval by ACC ASA's general meeting. - SLB Capturi has reached significant industrial milestones with the hand-over of the modular carbon capture facility at Twence, and the award of an EPCIC contract for a Just Catch 400 unit to Hafslund Celsio. Mainstream Renewable Power reports projects in South Africa progressing toward COD, and an improved commercial margin in the Andes portfolio: - Two projects for a combined ~150 MW under construction in South Africa are progressing toward COD in Q2 2025 and early 2026. - The commercial margin in the Andes portfolio in Chile showed continued positive development in Q4. - Cost optimization initiatives are well underway targeting a ~65% decrease in payroll and overhead cost. Aker Horizons Asset Development signed a term sheet for offtake from Narvik Green Ammonia (NGA), and is developing the Powered Land business: - A term sheet for 150 ktpa offtake from NGA was signed with VNG. - A collaboration agreement was signed with a major European utility targeting an ownership share in NGA post DG2. - The Kvandal site in Northern Norway is ready-to-build with 230 MW for power intensive industries. SuperNode is planning the full-scale testing of their superconducting technology this year: - A full-scale prototype of SuperNode's superconducting system is to be tested in the company's own facility H1 2025. - A first full-scale demo in a real TSO environment is to be conducted at the National Grid Deeside facility later in 2025. Aker Horizons reports net capital employed to reflect a portfolio composed mainly of unlisted assets. Net capital employed includes Aker Horizons' initial investment in the portfolio company, adjusted for any profit or loss and any additional investments, adjusted for foreign exchange fluctuations. As of the fourth quarter, Aker Horizons had NOK 2.4 billion net capital employed in ACC, NOK 2.5 billion in Mainstream, NOK 524 million in AAD, NOK 210 million in SuperNode and NOK 365 million in other assets. The Q4 2024 presentation is attached. Aker Horizons' CEO Lars P. Sørvaag Sperre and CFO Kristoffer Dahlberg, and Mainstream's CFO Julie Berg will present the main developments in the fourth quarter 2024 today at 08:30 CET, followed by a Q&A session. The presentation, which is open to all, will be held in English and will be webcast on Aker Horizons' website: https://akerhorizons.com/investors For further information, please contact:Jonas Gamre, Investor Relations, tel: +47 97 11 82 92, email: jonas.gamre@akerhorizons.com Mats Ektvedt, Media, tel: +47 41 42 33 28, email: mats.ektvedt@corporatecommunications.no About Aker Horizons Aker Horizons develops green energy and green industry to accelerate the transition to Net Zero. The company is active in renewable energy, carbon capture and sustainable industrial assets. As part of the Aker group, Aker Horizons applies industrial, technological and capital markets expertise with a planet-positive purpose to drive decarbonization globally. Aker Horizons is listed on the Oslo Stock Exchange and headquartered in Fornebu, Norway. Across its portfolio, the company is present on five continents. www.akerhorizons.com This information is considered to be inside information pursuant to the EU Market Abuse Regulation and is subject to the disclosure requirements in Regulation EU 596/2014 and the Norwegian Securities Trading Act § 5-12. This stock exchange announcement was published by Mats Ektvedt, Partner in Corporate Communications, on 13 February 2025 at 07:00 CET. This information was brought to you by Cision http://news.cision.com https://news.cision.com/aker-horizons/r/aker-horizons-asa--fourth-quarter-results-2024,c4104928 The following files are available for download: https://mb.cision.com/Public/20659/4104928/be606aed60f4f527.pdf Aker Horizons Q4 2024 Presentation
FORNEBU, Norway, Feb. 13, 2025 /PRNewswire/ -- Aker Carbon Capture ASA (ACC), an Aker Horizons portfolio company, today announced that the Board of Directors of ACC has proposed an extraordinary cash dividend of NOK 3.5 billion, of which Aker Horizons is expected to receive approximately NOK 1.5 billion based on its 43.27% ownership in ACC. In June 2024, ACC and SLB announced the completion of a transaction combining their carbon capture businesses in a joint venture (JV), since renamed SLB Capturi. ACC retains a 20% ownership stake in the JV and SLB holds the remaining 80%. ACC booked a gain on the sale of NOK 4.9 billion in its consolidated accounts. Going forward, ACC will, through its ownership in SLB Capturi, continue to support the development of the carbon capture business of SLB Capturi. The cash position remaining in ACC following the proposed dividend distribution will enable ACC to retain a sufficiently robust balance sheet to fulfill its role and responsibilities as a minority owner of SLB Capturi, and will back ACC's remaining pro-rata guarantee exposure for projects awarded prior to the formation of the JV. ACC's proposed cash dividend is among other things subject to approval by an extraordinary general meeting in ACC, expected to be held on or about 7 March 2025. Please refer to ACC's announcement for more details. For further information, please contact: Jonas Gamre, Investor Relations, Tel: +47 97 11 82 92jonas.gamre@akerhorizons.com Mats Ektvedt, Media, Tel: +47 41 42 33 28mats.ektvedt@corpcom.no About Aker Horizons: Aker Horizons develops green energy and green industry to accelerate the transition to Net Zero. The company is active in renewable energy, carbon capture and sustainable industrial assets. As part of the Aker group, Aker Horizons applies industrial, technological and capital markets expertise with a planet-positive purpose to drive decarbonization globally. Aker Horizons is listed on the Oslo Stock Exchange and headquartered in Fornebu, Norway. Across its portfolio, the company is present on five continents. www.akerhorizons.com About Aker Carbon Capture: Aker Carbon Capture ASA was established as a separate entity in 2020, building on more than 20 years long experience and maturation of the carbon capture technology within Aker. Following an agreement with SLB, a joint venture between SLB and Aker Carbon Capture was established This information was brought to you by Cision http://news.cision.com https://news.cision.com/aker-horizons/r/aker-carbon-capture-proposes-a-cash-dividend-of-nok-3-5-billion,c4104692
GOTHENBURG, Sweden, Feb. 7, 2025 /PRNewswire/ -- In September 2024, SKF announced the decision to initiate a separation of its Automotive business with the objective of a separate listing on Nasdaq Stockholm through a Lex Asea distribution to its shareholders. As the separation process continues, SKF now launches a consent solicitation to holders of its notes, in relation to the contemplated spin-off and to confirm that it will not cause an event of default under the conditions of the notes. SKF is seeking the consent as a matter of prudence and in order to avoid any potential uncertainty in the future. SKF does not consider that there has been an event of default under any series of the notes. As previously communicated, SKF considers that the contemplated spin-off of its automotive business would facilitate a clearer focus on distinct opportunities to enhance customer value, accelerate growth, improve competitiveness as well as providing long-term value benefiting customers, employees and other stakeholders. SKF does not expect the contemplated spin-off to have any negative impact on its strategy, operational or financial conditions of SKF. This implies that the contemplated spin-off would not impact the solvency of SKF and its financial structure would remain solid. As further described in the announcement, SKF is offering a 0.25% (as a percentage of the principal amount) early voting fee to Noteholders who vote in favour of the approvals at or prior to the applicable early instruction deadline. For further information, please see the announcement in respect of the consent solicitation which will be published here: https://www.luxse.com/market-overview/market-news. Aktiebolaget SKF (publ) Information in this press release contains information that AB SKF is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, on 7 February 2025 at 08:00 CET. DISCLAIMER Neither the Consent Solicitation Memorandum, the announcement, nor this press release constitutes an invitation to participate in the consent solicitation in any jurisdiction in which, or to any person to whom, it is unlawful to make such invitation or for there to be such participation under applicable securities laws or regulations. The distribution of the Consent Solicitation Memorandum, the announcement and this press release in certain jurisdictions may be restricted by laws or regulations. Persons into whose possession the Consent Solicitation Memorandum, the announcement and this press release comes are required by each of Aktiebolaget SKF (publ), the Solicitation Agents, the Fiscal Agents, and the Information and Tabulation Agent to inform themselves about, and to observe, any such restrictions. None of Aktiebolaget SKF (publ), the Solicitation Agents, the Fiscal Agents or the Information and Tabulation Agent will incur any liability for its own failure or the failure of any other person or persons to comply with the provisions of any such restrictions. Neither the Consent Solicitation Memorandum, the announcement, nor this press release is an offer of securities for sale in the United States or to any U.S. person. Securities may not be offered or sold in the United States absent registration or an exemption from registration. The notes have not been, and will not be, registered under the Securities Act, or the securities laws of any state or other jurisdiction of the United States, and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons, unless an exemption from the registration requirements of the Securities Act is available. For the purpose of the Consent Solicitation Memorandum, the announcement and this press release, "United States" means the United States of America, its territories and possessions, any state of the United States of America and the District of Columbia. Terms used in this paragraph have the meaning given to them by the Securities Act. In addition, the communication of the Consent Solicitation Memorandum, this press release and any other documents or materials relating to the Proposal is not being made, and such documents and/or materials have not been approved, by an authorised person for the purposes of section 21 of the Financial Services and Markets Act 2000 ("FSMA"). Accordingly, such documents and/or materials are not being distributed to, and must not be passed on to, the general public in the United Kingdom. Such documents and/or materials are only directed at and may only be communicated to (1) any person within Article 43(2) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, which includes a creditor or member of Aktiebolaget SKF (publ), and (2) to any other persons to whom these documents and/or materials may lawfully be communicated in circumstances where section 21(1) of the FSMA does not apply. For further information, please contact:PRESS: Carl Bjernstam, Head of Media Relationstel: 46 31-337 2517; mobile: 46 722-201 893; e-mail: carl.bjernstam@skf.com Group Treasurer: Elisabeth Mosséen, tel: +46 31-337 6431; mobile: +46 722 156 431; e-mail: elisabeth.mosseen@skf.com This information was brought to you by Cision http://news.cision.com https://news.cision.com/skf/r/skf-continues-the-preparations-for-the-separation-of-its-automotive-business--initiates-consent-soli,c4101451 The following files are available for download: https://mb.cision.com/Main/637/4101451/3251832.pdf 20250207 SKF continues the preparations for the separation of its Automotive business, initiates consent solicitation https://news.cision.com/skf/i/dji-0831,c3374835 DJI 0831
GOTHENBURG, Sweden, Feb. 6, 2025 /PRNewswire/ -- Full Year 2024 2024 revenue was SEK 400.2 bn (SEK 399.3 bn in 2023) 2024 operating income (excl. JVs and associates) was SEK 27.0 bn (SEK 25.6 bn in 2023) 2024 operating income was SEK 22.3 bn (SEK 19.9 bn in 2023) 2024 EBIT margin (excl. JVs and associates) was 6.8 per cent (6.4 per cent in 2023) 2024 EBIT margin was 5.6 per cent (5.0 per cent in 2023) 2024 basic earnings per share was SEK 5.17 (SEK 4.38 in 2023) 2024 fully electric car sales share at 23 per cent (16 per cent in 2023) 2024 free cash flow of SEK 1.1 bn (SEK –9.0 bn in 2023) Quarter 4, 2024 Q4 revenue was SEK 112.1 bn (SEK 109.4 bn SEK in Q4 2023) Q4 operating income (excl. JVs and associates) was SEK 6.3 bn (SEK 6.7 bn in Q4 2023) Q4 operating income was SEK 3.9 bn SEK (SEK 5.4 bn in Q4 2023) Q4 EBIT margin (excl. JVs and associates) was 5.6 per cent (6.1 per cent in Q4 2023) Q4 EBIT margin was 3.4 per cent (4.9 per cent in Q4 2023) Q4 basic earnings per share was SEK 0.84 (SEK 1.04 in Q4 2023) Q4 fully electric car sales share at 21 per cent (16 per cent in Q4 2023) Q4 free cash flow of SEK 13.6 bn (SEK 6.1 bn in Q4 2023) Volvo Cars had a second consecutive record-breaking year in 2024 and today reports the highest full-year retail sales, revenues and core operating profit in its 98-year history. However, the company anticipates a turbulent 2025 due to challenging market conditions. Full-year revenues exceeded SEK 400 billion for the first time in the company's history, due to a new all-time sales record of 763,389 cars. Its full-year core operating profit of SEK 27 billion, excluding joint ventures and associates, was another record and up 6 per cent compared to 2023. The core operating margin came in at 6.8 per cent, up from 6.4 per cent in 2023. Group operating income in the fourth quarter was affected by a SEK 1.7 bn write-down related to assets in the NOVO joint venture, before the company took full financial control of NOVO from an accounting perspective. Gross margins for the fourth quarter came in at 17.1 per cent, impacted by a one-time effect from the sale of on-balance sheet cars. This increased both revenue and cost of sales and lowered the Q4 gross margin. Volvo Cars also saw a considerably larger decrease in inventory during Q4 compared to the previous year, which further impacted gross margins. Margins were also affected by car line and sales channel mix as well as pricing pressure in the market, but this was partially offset by a more efficient cost structure for new car sales. The company's cash flow improved considerably in the latter part of the year and full-year free cash flow ended up positive at SEK 1.1 billion, thanks to diligent and disciplined cash management. "2024 was a year of two halves," said Jim Rowan, chief executive for Volvo Cars. "For the first six months, we recorded strong double-digit volume growth. But like the rest of the industry, we experienced a more challenging second half. Demand slowed down and this had an impact on both our sales pace and underlying profitability. Nevertheless, we can look back at 2024 with a sense of achievement in several areas and we are positioned well to achieve our long-term ambitions." The company's 2024 results show that despite challenges, Volvo Cars performed better than most of its peers in the premium segment in terms of volume growth and demonstrated resilience. This also underlines the strength of its balanced product portfolio, which contains both electric cars as well as plug-in and mild hybrid models. The company sold 175,194 fully electric cars in 2024, an increase of 54 per cent versus 2023 and representing 23 per cent of its total global sales volume, which was the highest share among all legacy premium carmakers. Sales of fully electric and plug-in hybrid models amounted to 46 per cent of all Volvo cars sold in 2024. This strong performance enabled Volvo Cars to exceed its CO2 targets as set by the EU, giving it a surplus of EU carbon credits in 2025. The full CEO letter by Jim Rowan, with more details on the past year and the years ahead, is included in the interim report for the period and can be found here. Looking ahead to 2025 While the company expects the market to remain weak in 2025, due to the multitude of competitive and geopolitical challenges, Volvo Cars is coming into 2025 in a solid position with strong liquidity, on the back of two record years of sales and profits. The company's focused strategy, balanced footprint, technological development and diversified line-up will help it navigate challenges and pave the way for its long-term future growth. It will continue to invest in and strengthen its diversified and balanced product line-up, with five new or refreshed versions of existing models coming on the market in 2025. Volvo Cars expects that these cars will help it partly mitigate the challenging market conditions in 2025. Volvo Cars continues to double down on internal cost actions and efficiency with heightened focus on protecting cash and efficiently managing its inventories, while continuing to invest in its future. Volvo Cars is currently at the peak of its investment cycle, which will decline as planned from 2026 onwards and unlock strong, positive free cash flows. Nevertheless, competitive pressures have increased considerably. Additionally, the strong orderbook the company developed in the last two years has now returned to pre-pandemic levels. While a smaller order book is good for customers as it results in shorter lead times, it does present the company with a challenge, particularly for the first six months of 2025, which it will manage. This means that while Volvo Cars maintains its guidance on outgrowing the market between 2023-2026 on a CAGR basis, delivering a core EBIT margin of 7-8 per cent and generating a strong positive free cash flow in 2026, it anticipates that 2025 will be a challenging and transition year on the path to its long-term growth ambitions. The company does not anticipate the market to grow at the rate of previous years, coupled to a highly likely increase in discounts across the industry due to increased competition. As a result, Volvo Cars anticipates it will be challenging to reach the volumes and profitability level it achieved in 2024. It also sees effects on profitability from higher amortisations as it continues to ramp up its new cars, such as the EX90 and the ES90 in 2025. However, Volvo Cars continues to focus on cash preservation and anticipates it can deliver a positive free cash flow for the full year 2025, compared to its previous guidance of neutral free cash flow. "2025 will be a year of transition," said Jim Rowan. "The global car industry is facing several uncertainties: cyclical, structural, transformational and geopolitical. We have navigated this environment better and faster than many of our peers, but we and the rest of the industry will be severely tested this year. At the same time, we must keep our eyes firmly on the road ahead and not sacrifice the future on the altar of the present. In other words, we must be prudent, diligent and disciplined during a turbulent 2025, while paving the way for our long-term ambitions." Note to editors Jim Rowan, chief financial officer Johan Ekdahl and chief engineering and technology officer Anders Bell will host a livestream on Volvo Cars' 2024 results for media, investors and analysts at 08:00 CET today. The presentation will be held in English and followed by a Q&A session. Link for livestream: https://live.volvocars.com China-only link for livestream: https://live.volvocars.com.cn It will be possible to ask questions during the Q&A session following the main presentation. To participate, you can either use the chat function online to type your question or you can call in. To call in, participants need to register via the link below and will then receive the dial-in details and individual PIN. Link to register This disclosure contains information that Volvo Car AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 06-02-2025 07:00 CET. For further information please contact:Volvo Cars Media Relations+46 31-59 65 25media@volvocars.comVolvo Cars Investor Relations John Hernander+46 31-793 94 00investors@volvocars.com This information was brought to you by Cision http://news.cision.com. https://news.cision.com/volvo-car-ab--publ-/r/volvo-cars-reports-second-consecutive-year-of-record-sales--revenue-and-profits-in-2024--anticipates,c4101417 The following files are available for download: https://mb.cision.com/Main/20685/4101417/3249058.pdf Volvo Car Group_Q4_2024_ENG https://news.cision.com/volvo-car-ab--publ-/i/image-ex90-5-feb,c3374757 Image EX90 5 feb
PERTH, Australia, Feb. 6, 2025 /PRNewswire/ -- Argent BioPharma (ASX: RGT) (OTCQB: RGTLF), a clinical-stage biopharmaceutical company brings hope to epilepsy patients. For thousands of patients with refractory epilepsy—commonly referred to as drug-resistant epilepsy—the search for effective treatment often feels like navigating an endless maze. These individuals, about 30% of the epilepsy community, live with seizures that persist despite conventional therapies. Now, a groundbreaking solution, CannEpil®, is offering hope. Developed by Argent BioPharma Limited, CannEpil® is an oral mucosal solution with a high-CBD, low-THC formulation. It is designed to reduce seizure frequency and severity while minimizing psychoactive effects. After years of clinical development, CannEpil® is making waves in the UK as part of a movement to transform severe epilepsy treatment. This breakthrough follows GW Pharmaceuticals' $7.2 billion acquisition, highlighting the potential of cannabis-based epilepsy treatments. Argent BioPharma's CannEpil® is poised to follow a similar trajectory, offering a novel solution for drug-resistant epilepsy patients worldwide. A Milestone for UK Patients The journey of CannEpil® in the UK has been historic. In collaboration with the I AM Billy Foundation—named after Billy Caldwell, a young boy whose severe epilepsy sparked a national conversation about medical cannabis—the first UK patient has received CannEpil® under the NHS's Refractory Epilepsy Specialist Clinical Advisory Service (RESCAS). The inclusion of CannEpil® in the UK's Named Patient Request system is a game-changer. This pathway allows doctors on the General Medical Council (GMC) Specialist Register to prescribe it to patients with urgent medical needs. For families who have struggled for years, this development is a much-needed lifeline. What Makes CannEpil® Stand Out? CannEpil®'s success lies in its rigorous clinical testing and safety profile. A notable Australian study confirmed it does not impair driving performance, offering reassurance to patients and families. Its rollout in Ireland in 2019, under full governmental health insurance, marked the beginning of its international impact. Now, with availability in the UK, CannEpil® is not just a treatment—it is a symbol of progress in the fight against drug-resistant epilepsy. Its high-CBD content, known for its anti-seizure properties, provides an effective alternative for patients who have exhausted other options. Additionally, CannEpil® has undergone rigorous clinical evaluation, with studies demonstrating a strong safety profile, including evidence that it does not impair activities such as driving. This focus on efficacy and safety sets CannEpil® apart as a leading option for refractory epilepsy patients who have not responded to conventional treatments. Edison Report:https://argentbiopharma.com/research_reports/ Argent BioPharmaRoby ZomerCEO & Managing Director+61 8 6555 2950info@argentbiopharma.com Argent BioPharmaRowan HarlandCompany Secretary+61 8 6555 2950info@argentbiopharma.com
A12 藝術空間
Accounting news, issues
請先登入後才能發佈新聞。
還不是會員嗎?立即 加入台灣產經新聞網會員 ,使用免費新聞發佈服務。 (服務項目) (投稿規範)